Novel Lipoprotein (a) Therapies: A Comprehensive Review
Curr Atheroscler Rep. 2026 Aug 13;28(1):81. doi: 10.1007/s11883-026-01453-9.ABSTRACTPURPOSE OF REVIEW: Lipoprotein(a) [Lp(a)] is a genetically determined, independent risk factor for atherosclerotic cardiovascular disease and calcific aortic valve stenosis. Plasma Lp(a) levels are 70-90% heritable,

